Author:
Hadji Peyman,Asmar Lina,van Nes Johanna G. H.,Menschik Thomas,Hasenburg Annette,Kuck Joachim,Nortier Johan W. R.,van de Velde Cornelis J. H.,Jones Stephen E.,Ziller May
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference33 articles.
1. Coates AS, Keshaviah A, Thurlimann B et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1–98. J Clin Oncol 25:486–492
2. Coleman RE, Banks LM, Girgis SI et al (2007) Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the intergroup exemestane study (IES): a randomised controlled study. Lancet Oncol 8:119–127
3. Coleman RE, Banks LM, Girgis SI et al (2008a) Reversal of skeletal effects of endocrine treatments in the intergroup exemestane study. Poster presentation at San Antonio Breast Cancer Symposium (SABCS), San Antonio, Texas, USA, 10–14 December
4. Coleman RE, Bolten WW, Lansdown M et al (2008b) Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations. Cancer Treat Rev 34:275–282
5. Coombes RC, Hall E, Gibson LJ et al (2004) A randomized trial of exemestane after 2–3 years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081–1092
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献